捕捉键的分子机制及其对血小板血静的影响
Aleksey V Belyaev1, Irina V Fedotova1
1Faculty of Physics, M.V.Lomonosov Moscow State University, 1, Leninskiye Gory, build.2, Moscow, 119991 Russia.
Biophysical reviews
|November 17, 2023
概括
分子捕捉键在强力下加强,对于血液细胞粘附在血液静止和免疫力至关重要. 这篇评论探讨了它们的生物力学以及它们在血小板血栓形成中的作用.
科学领域:
- 生物物理学的生物物理.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 粘性分子键介导关键的血细胞功能,如血小板粘附和聚合在流动的血液.
- 捕获键是一种独特的非共价生物分子相互作用类,在应用拉力时,其解离寿命会增加.
- 这些键被越来越多地认识到它们在血液静止,免疫力和预防出血方面的重要作用.
研究的目的:
- 审查目前的实验发现和有关血液细胞捕获纽带的理论见解.
- 阐明控制捕捉键行为的分子生物力学原理.
- 为了检查捕获债券在血小板血栓形成和血液静止中的意义.
主要方法:
- 对实验发现和理论模型的文献评论.
- 在分子层面分析生物力学原理.
- 综合了血液细胞相互作用中的捕获键功能的数据.
主要成果:
- 捕获债券在增加力度提高其稳定性的情况下发挥了反直觉的作用.
- 这些纽带对于血小板在血栓形成和血液静止期间的正常功能至关重要.
- 最近的发现强调了它们在免疫反应和感染预防方面的重要性.
结论:
- 捕获键代表了血液细胞动态中的关键分子机制.
- 了解捕捉键生物力学,可以了解静血和免疫过程.
- 对捕获键的进一步研究可以为出血障碍和血栓形成的治疗策略提供信息.
相关概念视频
Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
713
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
713
Introduction to Hemostasis
8.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
534
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
534
Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K


